NEOG — Neogen Corporation stock price, charts and financials

QT84Neogen Corporation

Neogen Corporation (NASDAQ: NEOG) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
13.00
+0.17+1.32%
NEOGQT84Neogen Corporation·NASDAQ
13.00+1.32%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E-EPS (ttm)-0.03Insider Own3.29%Shs Outstand218.06MPerf Week10.36%
Market Cap2.83BForward P/E31.71EPS next Y0.41Insider Trans0.01%Shs Float216.50MPerf Month7.00%
Enterprise Value3.44BPEG-EPS next Q0.05Inst Own-Short Float4.89%Perf Quarter39.63%
Income-7.94MP/S3.26EPS this Y1133.33%Inst Trans-Short Ratio5.36Perf Half Y49.43%
Sales870.38MP/B1.35EPS next Y32.26%ROA-0.24%Short Interest10.58MPerf YTD85.98%
Book/sh-P/C34.02EPS next 5Y14.88%ROE-0.37%52W High13.07 -0.54%Perf Year138.10%
Cash/sh-P/FCF88.86EPS past 3/5Y-ROIC-0.60%52W Low5.10 154.90%Perf 3Y-39.32%
Dividend Est.-EV/EBITDA20.01Sales past 3/5Y1.91% 13.20%Gross Margin46.93%Volatility3.56% 3.33%Perf 5Y-69.38%
Dividend TTM-EV/Sales3.96EPS Y/Y TTM99.40%Oper. Margin-2.49%ATR (14)0.43Perf 10Y-41.39%
Dividend Ex-Date-Quick Ratio2.91Sales Y/Y TTM-2.79%Profit Margin-0.91%RSI (14)73.85Recom2.64
Dividend Gr. 3/5Y-Current Ratio3.82EPS Q/Q280.00%SMA208.92%Beta1.78Target Price13.00
Payout0.00%Debt/Eq0.38Sales Q/Q0.00%SMA5015.72%Rel Volume3.41Prev Close12.83
Employees2,636LT Debt/Eq0.38EarningsOct 06SMA20034.70%Avg Volume2.17MPrice13.00
IPO DateAug 23, 1989Option/ShortYes / YesEPS/Sales Surpr.58.82% 6.10%Net Debt/EBITDA3.53Volume7,422,633Change1.32%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-26-26UpgradePiper SandlerNeutralOverweight
Aug-03-26ReiteratedPiper SandlerNeutral$10$13
Jan-12-26ReiteratedPiper SandlerNeutral$6.50$10
Jan-09-26ReiteratedGuggenheimBuy$12
Dec-10-25UpgradeCJS SecuritiesMarket PerformMarket Outperform
Oct-16-25ReiteratedPiper SandlerNeutral$5.00$6.50
Jul-29-25DowngradeWilliam BlairOutperformMarket Perform
Apr-22-25ReiteratedPiper SandlerNeutral$18$5.00
Aug-06-24ReiteratedPiper SandlerNeutral$17$18
Nov-22-22UpgradeWilliam BlairMarket PerformOutperform
Latest News· Times ET
Sep-15-26
Sep-14-26
Sep-11-26
Sep-10-26
Sep-08-26
Sep-08-2605:00AM
Sep-07-26
Sep-04-26
Aug-31-26
Aug-26-26
Aug-24-26
Aug-19-26
Aug-11-26
Company

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2026
5/31/2026
FY 2025
5/31/2025
FY 2024
5/31/2024
FY 2023
5/31/2023
FY 2022
5/31/2022
FY 2021
5/31/2021
FY 2020
5/31/2020
FY 2019
5/31/2019
Total Revenue870870895
Cost of Goods Sold Incl. D&A462462473
Gross Profit409409421
Selling, General and Administrative Excl. Other412412402
Research and Development191821
Other Operating Expense-10-11
Operating Income-21-229
Interest Expense595872
Unusual Expense
Non-Operating Income (Expense)7270-1,071
Net Income Before Taxes-8-9-1,133
Income Taxes-1-1-41
Consolidated Net Income-8-8-1,092
Net Income From Continuing Operations-8-8-1,092
Net Income-8-8-1,092
EPS (Recurring)-0.03-0.04-5.03
EPS (Basic, Before Extraordinaries)-0.03-0.04-5.03
EPS (Diluted)-0.03-0.04-5.03
EBITDA172171-938
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio
Price To Sales Ratio3.262.251.42
Gross Margin47.0147.0147.04
Operating Margin-2.41-2.531.01
Net Margin-0.92-0.92-122.01
Shares Outstanding218218217
Market Capitalization2,8341,9551,272
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$14.25$11.54$8.82$6.11$3.40 Close Price0.00K1.09K2.19K3.28K4.37KUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Nassif MikhealCEOAug 04 '26Buy11.813704,3701,074Aug 06
Rocklin Amy MFormer Chief Legal OfficerMay 18 '26Option Exercise9.2935,183326,85092,423May 19
Moylan John PatrickChief Accounting OfficerMay 04 '26Option Exercise9.534,55843,43818,905May 05
Nassif MikhealCEOFeb 17 '26Buy10.9423252704Feb 17
Nassif MikhealCEOFeb 02 '26Buy10.0024240681Feb 02
Nassif MikhealCEOJan 26 '26Buy9.8625246657Feb 02
Nassif MikhealCEOJan 16 '26Buy9.331371,279632Jan 16
Naemura David H.Former CFODec 01 '25Option Exercise5.9812,91277,21493,936Dec 02
Nassif MikhealCEONov 03 '25Buy6.251771,106495Nov 07
BOREL JAMES CDirectorOct 27 '25Option Exercise6.193,80223,53596,347Oct 29
CAPELLO JEFFREY DDirectorOct 27 '25Option Exercise6.193,80223,53532,502Oct 29
Green Ronald DDirectorOct 27 '25Option Exercise6.191,77711,00018,654Oct 29
Gupta AashimaDirectorOct 27 '25Option Exercise6.191,77711,00027,790Oct 29
RODRIGUEZ RAFAEL ADirectorOct 27 '25Option Exercise6.191,77711,00020,821Oct 28
Tobin James PDirectorOct 27 '25Option Exercise6.191,77711,00043,347Oct 28
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.